Agneta Svedberg

Agneta Svedberg has a diverse work experience in the pharmaceutical industry. Agneta worked as the VP of Clinical Development & Pharmacovigilance at Camurus from 2015 till present. Prior to that, they served as the Chief Operating Officer at Zealand Pharma from 2013 to 2015 and CEO at Cantargia AB from 2011 to 2013. Agneta also worked as a Senior Advisor at Semcon Drug Development Consulting from 2010 to 2011. Before that, they had a long tenure at Genmab A/S, where they held various positions including Senior Vice President and Copenhagen Site Manager, as well as Vice President and Director of Clinical Development. Agneta has also worked at OXiGENE, Inc. as the Head of Clinical Development, Europe, and at Pharmacia and Upjohn as a Senior Clinical Research Manager. Agneta'searlier experience includes being a Clinical Research Manager at Pharmacia & Upjohn AB in Helsingborg and Lund, Sweden. Throughout their career, Agneta has demonstrated skills in clinical development, project management, and leadership.

Agneta Svedberg's education history begins in 1985 when they enrolled at Lund University to pursue a degree in Medicine. They completed their MB degree in Medicine in 1987. Simultaneously, they pursued a degree in Radiation Physics, earning their MSc in 1988 from the same university.

In 2001, Agneta Svedberg attended SIMI in Copenhagen, Denmark, where they obtained a diploma in Managing Medical Product Innovation.

A few years later, from 2006 to 2008, Agneta Svedberg pursued an E*MBA degree at Lund University, although the field of study for this degree is not specified.